Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid β-induced cognitive deficits associated with decreased amyloid β accumulation.
about
Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and CognitionPhosphodiesterases as therapeutic targets for Alzheimer's disease.Cilostazol Modulates Autophagic Degradation of β-Amyloid Peptide via SIRT1-Coupled LKB1/AMPKα Signaling in Neuronal CellsBridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive PotentialPhosphodiesterase III inhibitor promotes drainage of cerebrovascular β-amyloidCilostazol add-on therapy in patients with mild dementia receiving donepezil: a retrospective studyPMC-12, a Prescription of Traditional Korean Medicine, Improves Amyloid β-Induced Cognitive Deficits through Modulation of Neuroinflammation.Cilostazol Upregulates Autophagy via SIRT1 Activation: Reducing Amyloid-β Peptide and APP-CTFβ Levels in Neuronal CellsActivating mitochondrial function and haemoglobin expression with EH-201, an inducer of erythropoietin in neuronal cells, reverses memory impairmentConcurrent Treatment with Taxifolin and Cilostazol on the Lowering of β-Amyloid Accumulation and Neurotoxicity via the Suppression of P-JAK2/P-STAT3/NF-κB/BACE1 Signaling Pathways.Cilostazol as an add-on therapy for patients with Alzheimer's disease in Taiwan: a case control study.Mitochondrial Ferritin Deletion Exacerbates β-Amyloid-Induced Neurotoxicity in MiceOctodon degus: a model for the cognitive impairment associated with Alzheimer's disease.Investigational phosphodiesterase inhibitors in phase I and phase II clinical trials for Alzheimer's disease.Cilostazol suppresses β-amyloid production by activating a disintegrin and metalloproteinase 10 via the upregulation of SIRT1-coupled retinoic acid receptor-β.Attenuation of β-amyloid-induced tauopathy via activation of CK2α/SIRT1: targeting for cilostazol.Protection by cilostazol against amyloid-β(1-40)-induced suppression of viability and neurite elongation through activation of CK2α in HT22 mouse hippocampal cells.Cilostazol improves cognitive function in patients with mild cognitive impairment: a retrospective analysis.Aβ Peptide Originated from Platelets Promises New Strategy in Anti-Alzheimer's Drug Development.Changes of hypoxia-inducible factor-1 signaling and the effect of cilostazol in chronic cerebral ischemia.A multicenter, randomized, placebo-controlled trial for cilostazol in patients with mild cognitive impairment: The COMCID study protocol.Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain.From Age-Related Cognitive Decline to Alzheimer's Disease: A Translational Overview of the Potential Role for Phosphodiesterases.Regulation of NADPH oxidase gene expression with PKA and cytokine IL-4 in neurons and microglia.Cilostazol improves hippocampus-dependent long-term memory in mice.Comprehensive effects of galantamine and cilostazol combination therapy on patients with Alzheimer's disease with asymptomatic lacunar infarction.Cilostazol Use Is Associated with Reduced Risk of Dementia: A Nationwide Cohort Study.Antithrombotic therapies for elderly patients: handling problems originating from their comorbidities
P2860
Q26771954-C8A92341-7367-4887-8632-C071AB6905B7Q28279704-F59D1B34-F710-40D7-AE36-86313C3EDCE3Q28553396-3E5A3583-FA35-48C9-B4F5-4128736ADA6BQ29994589-9AA617E6-23E8-4D31-86EE-AA974575ED57Q34286389-C0D68707-EC7B-4B9E-B8BE-FC87A2788A97Q35107521-0C5BCEA3-2475-42BB-9F1C-18B5CCFEDC08Q35511034-437C460A-0601-48F9-BBAE-D3652893EC1FQ35921338-7A291689-0B6C-4F55-95AA-91358D917FB9Q36124238-2A2DCED7-F67E-491E-8698-B83A72F5EB12Q36225127-AD24AFA8-718E-4D0B-800F-C86FA034FCDCQ36288900-41396C73-843A-4FC0-ACA1-1F39050A7904Q37612064-B784D24E-0914-4F5C-92E0-9BEFC3E81179Q38109655-ABB18C82-9699-409A-9CA6-DDD1DBD37AB4Q38643963-EE26A93B-4209-4D63-B56F-688C911E7BF8Q38987753-96921FAE-C7C3-448B-90AF-A20F96E67C31Q39061079-E6C8B625-4743-455C-BE10-73E8C055FB99Q39378771-A40E369B-CB07-42AC-A178-8B360E6B74EFQ41365399-90147E5C-58D8-4554-8BDC-62026895F1AEQ42002912-88B8CAF0-C027-4FBA-8F64-195E2261DCD6Q42120491-D3C32E50-CCB1-4DD3-8E3F-A4391EE68676Q42656245-70313091-7DF2-4D95-860A-63CB5F8A0155Q45305673-185B2F40-C162-43E5-B604-890B6524145AQ47611446-74F27930-F1D1-4AE6-BB6A-833C5A38290DQ47796860-D3E140D7-588A-43B5-A643-3BA02C5696DFQ47925672-676056BB-C95C-48B0-90A4-BE96BB2DE664Q48043052-DA938631-721A-4ED1-8DF8-E5D5455C1180Q53689882-BEEFE7DB-9A29-4470-BF38-BA4DE4D468DFQ58751103-EE9DCA02-CA4F-448E-ACE9-A698DA0C6433
P2860
Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid β-induced cognitive deficits associated with decreased amyloid β accumulation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Protective effect of the phosp ...... reased amyloid β accumulation.
@en
Protective effect of the phosp ...... reased amyloid β accumulation.
@nl
type
label
Protective effect of the phosp ...... reased amyloid β accumulation.
@en
Protective effect of the phosp ...... reased amyloid β accumulation.
@nl
prefLabel
Protective effect of the phosp ...... reased amyloid β accumulation.
@en
Protective effect of the phosp ...... reased amyloid β accumulation.
@nl
P2093
P1476
Protective effect of the phosp ...... reased amyloid β accumulation.
@en
P2093
Byung Tae Choi
Dong-Seok Lee
Hwa Kyoung Shin
Jae Yoon Leem
Ji Hyun Kim
Ki Whan Hong
Sun Haeng Park
Sun Sik Bae
P304
P356
10.1016/J.BBRC.2011.04.068
P407
P577
2011-04-22T00:00:00Z